Skip to main content

Month: March 2024

X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Launch preparations underway in anticipation of possible U.S. approval of mavorixafor for WHIM syndrome; U.S. PDUFA target action date set for April 30, 2024 Additional Phase 2 clinical data and initiation of global Phase 3 clinical trial of mavorixafor for the treatment of certain chronic neutropenic disorders expected in 1H24 Conference call to be hosted today at 8:30 a.m. ET BOSTON, March 21, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted key 2023 events and expected upcoming milestones. “Following an incredibly productive 2023, we are expecting a transformative year in 2024,” said Paula Ragan, Ph.D., President and...

Continue reading

Azrieli Group Reports Q4/2023 and Y2023 Results

For the first time, the annual NOI and net profit have crossed the NIS 2 billion mark In Y2023, NOI was up some 8%, totaling around NIS 2,113 million; net of a one-time expense for the relief given to tenants, NOI would have been NIS 2,148 million – up 10% FFO in Y2023 was up some 7% totaling around NIS 1,461 million; FFO (excluding senior housing) in Y2023 was up some 7% totaling around NIS 1,358 million Following the closing of the transaction for the sale of Compass, the Group increased the planned dividend, and will distribute approx. NIS 1 billion Danna Azrieli, Chairwoman of Azrieli Group: “2023 was a challenging year for Israeli society, even before the outbreak of the Iron Swords War. Despite this, we are ending the year with continued growth in all of the parameters, and we view this as tangible evidence of the leadership and...

Continue reading

Li Auto Inc. Updates First Quarter Delivery Outlook

BEIJING, China, March 21, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today provided an updated delivery outlook for the first quarter of 2024. Due to lower-than-expected order intake, the Company now expects its vehicle deliveries for the first quarter of 2024 to be between 76,000 and 78,000 vehicles, revised from the previous vehicle delivery outlook of between 100,000 and 103,000 vehicles. “I want to reflect on a couple of the key issues that we faced in March and provide some insights and solutions. “First, we want to acknowledge that the operating strategy of Li MEGA was mis-paced. We planned operations of Li MEGA as if the model had already entered the 1-to-10 scaling phase, while in fact, we were still in the nascent 0-to-1 business...

Continue reading

Cornish Metals Releases Audited Financial Statements and Management’s Discussion and Analysis for the Period Ended December 31, 2023

VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing the South Crofty tin project (“South Crofty” or the “Project”), located in Cornwall, United Kingdom, to a construction decision, is pleased to announce that it has released its annual audited financial statements and management’s discussion and analysis (“MD&A”) for the period ended December 31, 2023. The reports are available under the Company’s profile on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.cornishmetals.com). Highlights for the period ended December 31, 2023 and for the period ending March 20, 2024 (All figures expressed in Canadian dollars unless otherwise stated)Refurbishment of New Cook’s...

Continue reading

Great Pacific Gold Announces High-Grade Assays on Follow Up at Comet Discovery

Example of CDH01A drill core annotated with gold grades in g/t. Core tray is 100m to 104.23mExample of CDH01A drill core annotated with gold grades in g/t. Core tray is 100m to 104.23mUpdated Comet Cross Section 5850100mNUpdated Comet Cross Section 5850100mNVANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) — Great Pacific Gold Corp. (“Great Pacific Gold,” “GPAC,” or the “Company”) (TSXV: GPAC) (OTCQX: FSXLF) (Germany: 4TU) is pleased to announce high-grade gold assays from its initial follow up diamond drill hole of the Comet gold discovery at the Lauriston Gold Project in Victoria, Australia. Diamond drill hole CDH01A intersected 4m at 25.1 g/t Gold from 99.5m including 0.4m at 72.5 g/t Gold from 99.5m and 1m at 55 g/t Gold from 102.5m, within a broader interval assaying 9m at 11.6...

Continue reading

Hearty Bay Drilling Suggests Till Sampling May Lead to Source of Radioactive Boulders

Drill Program Suspended Due to Early Ice Road ClosureFigure 1Drilling UpdatedCALGARY, Alberta, March 21, 2024 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) announces the completion of a single sonic drill hole at the Hearty Bay Property (“The Property”) and the early suspension of the drill program due to deteriorating ice conditions on Lake Athabasca. The use of a track mounted sonic drill has resulted in the recovery of till for the first time under the lake in the up-ice direction from the high grade boulder trains on Isle Brochet and resulted in the recovery of a complete intersect of the underlying glacial till. Initial interpretation of this unit is favorable and suggests less post depositional disturbance than assumed, supporting the theory that the...

Continue reading

Ultimovacs ASA: Annual Report 2023

Oslo, 21 March 2024: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces that the Board of Directors of Ultimovacs ASA has approved the Annual Report and ESG Report for 2023. Please find a PDF version of the annual report, as well as the report in European Single Electronic Format (ESEF), as attachments to this release. The Annual Report is also available at the company’s website: www.ultimovacs.com This information is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act. For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA Email: je@radforsk.no Phone: +47 480 96 355 Carlos de Sousa, CEO Email: carlos.desousa@ultimovacs.com Phone:...

Continue reading

KH Group Plc’s Financial Statements Release for 1 January – 31 December: 2023 Profitability retained in a challenging market

KH Group Plc Stock Exchange Release 21.3.2024 klo 8.00 KH Group Plc’s Financial Statements Release for 1 January – 31 December 2023 Profitability retained in a challenging market This is the summary of the Financial Statements Release for 2023. The full Financial Statements Release is attached to this release and is also available on the company’s website at www.khgroup.com KH Group, October–December 2023 pro forma Net sales amounted to EUR 105.3 (114.3) million. Operating profit was EUR 4.7 (3.6) million. KH-Koneet’s net sales decreased significantly year-on-year due to the weakened general market situation. Profitability was supported by operational efficiency improvement and the machinery leasing business. Indoor Group’s net sales were nearly on a par with the corresponding period last year, and profitability improved when compared...

Continue reading

VEON 4Q23 trading update: Strong organic growth in revenue and EBITDA, solid execution of VEON 2.0 strategy

VEON 4Q23 trading update: Strong organic growth in revenue and EBITDA, solid execution of VEON 2.0 strategy Amsterdam, 21 March 2024 07:00AM CET – VEON Q4 and FY 2023 HighlightsQ4 revenue of USD 953 million, +1.4% YoY (+17.9% YoY in local currency normalised) and EBITDA of USD 364 million, -20.4% YoY (+24.9% YoY in local currency normalised) FY revenue of USD 3,698 million, -1.5% YoY (+17.9% YoY in local currency normalised) and EBITDA of USD 1,609 million, -7.9% (+24.9% YoY in local currency normalised) Q4 capex of USD 258 million, -1.8% YoY, with LTM capex intensity of 17.6% and FY capex of USD 651 million, -21.8% YoY, with LTM capex intensity of 17.6% Total cash and cash equivalents of USD 1.7 billion, with USD 1.3 billion at HQ and gross debt at USD 4.7 billion (decreased by USD 2.8 billion YoY), with net debt excluding lease liabilities...

Continue reading

IBA Reports Full Year 2023 Results

GROUP REVENUES UP 18.7% WITH OTHER ACCELERATORS UP 51.1% REBIT POSITIVE FOR FY23 WITH OTHER ACCELERATORS REBIT ALMOST QUADRUPLING MEDIUM TERM GUIDANCE REITERATED Louvain-la-Neuve, Belgium, 21 March 2024 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the 2023 financial year.(EUR 000) FY 2023 FY 2022 Variance Variance %Total Net Sales 428 717 361 270 67 447 18.7%  Proton Therapy 229 065                                             218 761 10 304 4.7%  Other Accelerators 133 742                                              88 538 45 204 51.1%  Dosimetry 65 910                                               53 971 11 939 22.1%REBITDA 19 308 21 571 -2 263 -10.5%    % of Sales 4.5% 6.0%    REBIT 6 417 11 050 -4 633 -41.9%    %...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.